Show simple item record

dc.contributor.authorThorat, MAen_US
dc.date.accessioned2016-07-26T12:04:07Z
dc.date.available2016-06-23en_US
dc.date.issued2016-07-06en_US
dc.date.submitted2016-07-08T13:09:28.212Z
dc.identifier.issn1741-7015en_US
dc.identifier.other10.1186/s12916-016-0648-9
dc.identifier.otherARTN 101en_US
dc.identifier.otherARTN 101en_US
dc.identifier.otherARTN 101en_US
dc.identifier.otherARTN 101en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/13684
dc.descriptionThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_US
dc.language.isoenen_US
dc.relation.ispartofBMC MEDICINEen_US
dc.subjectAspirinen_US
dc.subjectPreventionen_US
dc.subjectCanceren_US
dc.subjectCardiovascular diseaseen_US
dc.subjectBenefit-harm balanceen_US
dc.subjectBleedingen_US
dc.subjectGastrointestinalen_US
dc.subjectModellingen_US
dc.subjectPersonalised medicineen_US
dc.titleIndividualised benefit-harm balance of aspirin as primary prevention measure - a good proof-of-concept, but could have been better ...en_US
dc.typeArticle
dc.rights.holderThe Author(s). 2016
dc.identifier.doi10.1186/s12916-016-0648-9en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000379737500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume14en_US
qmul.funderCancer Prevention::Cancer Research UKen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record